期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 11, 页码 4821-4835出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI68523
关键词
-
资金
- Emergence 2011 [AFM 2012-0773]
- NIH [K01CA097953, R01CA098466, R03CA124692]
- CCTS [UL1TR000090]
Cachexia is a debilitating condition characterized by extreme skeletal muscle wasting that contributes significantly to morbidity and mortality. Efforts to elucidate the underlying mechanisms of muscle loss have predominantly focused on events intrinsic to the myofiber. In contrast, less regard has been given to potential contributory factors outside the fiber within the muscle microenvironment. In tumor-bearing mice and patients with pancreatic cancer, we found that cachexia was associated with a type of muscle damage resulting in activation of both satellite and nonsatellite muscle progenitor cells. These muscle progenitors committed to a myogenic program, but were inhibited from completing differentiation by an event linked with persistent expression of the self-renewing factor Pax7. Overexpression of Pax7 was sufficient to induce atrophy in normal muscle, while under tumor conditions, the reduction of Pax7 or exogenous addition of its downstream target, MyoD, reversed wasting by restoring cell differentiation and fusion with injured fibers. Furthermore, Pax7 was induced by serum factors from cachectic mice and patients, in an NF-kappa B dependent manner, both in vitro and in vivo. Together, these results suggest that Pax7 responds to NF-kappa B by impairing the regenerative capacity of myogenic cells in the muscle microenvironment to drive muscle wasting in cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据